
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : SCK CEN
Deal Size : Undisclosed
Deal Type : Collaboration
Navigo and SCK CEN Join Forces for Radiotheranostics R&D
Details : The two organizations aim to accelerate the development of radioligand therapies – highly specific, targeted therapies offering high efficacy with minimal side effects for cancer patients.
Product Name : Undislcosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 03, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : SCK CEN
Deal Size : Undisclosed
Deal Type : Collaboration
